SAGE Sage Therapeutics Inc. Gross Profitability Margin

Corporate emblem and logo of Sage Therapeutics Inc. (SAGE)

Sage Therapeutics, Inc. (SAGE) is ramping up Zurzuvae sales and expanding its neuropharmaceutical presence through strategic partnerships. The search for new molecules is based on automated screening. On GURU.Markets, the estimated gross margin demonstrates capital density, where 89.00 sets the current value of the indicator. The business relies on a sovereign cycle, making the asset a defensive tool independent of global macroeconomics.

Return on Gross Profit: Sage Therapeutics, Inc. (SAGE) for 07/04/2022 - 08/16/2025

Financial and market metric breakdowns for sagerx.com (SAGE)

- market value and analyst target forecast:
Fundamental valuation:SAGE, Sage Therapeutics Inc.
Flagship merchandise of Sage Therapeutics, Inc.

Gross margin dynamics serve as a key indicator of operational efficiency, reflecting the share of profit after deducting direct production costs. An analysis of sales margins allows for an assessment of the business's ability to convert revenue into resources for growth. For Sage Therapeutics, Inc. (SAGE), this metric is critical during the commercial rollout of CNS drugs, when cost-of-goods optimization determines financial stability prior to the release of new molecules.

Main competitors

Return on Gross Profit Biogen Corp|Return on Gross Profit NBIX|Regencell Corp (RGC) - Return on Sales by Gross Profit|Gross Margin AXSM|Return on Gross Profit ACADIA Pharmaceuticals ACAD|Gross Margin XENE (Xenon Pharmaceuticals Inc.)|VKTX (Viking Therapeutics, Inc.) - Gross Profitability Margin|SUPN - Gross Profitability|Catalyst Pharmaceuticals Inc (CPRX) - Return on Gross Profit|DNLI (Denali Corp) - Return on Gross Profit|Gross Profit Margin harmonybiosciences.com (HRMY)|Return on Gross Profit BHVN|Gross Margin Amylyx|Gross Margin TRVI|PRAX (Praxis Corp) - Gross Profit Rate|Gross Margin AVXL (anavex.com)|CBLL: Gross Return on Sales|PRTA - Gross Profitability|ALEC - Gross Margin|Annexon Inc. (ANNX) - Gross Profitability|Return on Gross Profit Omeros Corp|Return on Gross Profit NGNE|ACIU: Gross Profit Rate|Return on Gross Profit VYGR (Voyager Corp)|Return on Gross Profit Neumora NMRA|Gross Profitability Scilex Holding Company, Inc. SCLX|Gross Sales Margin Tevogen Bio Inc.|ACOG - Gross Profitability|Gross Sales Margin Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Return on Gross Profit|Cassava Sciences Inc (SAVA) - Gross Margin|Return on Gross Profit ASRT|Gross Margin coyatherapeutics.com|Gross Margin VTGN|Ovid Therapeutics - Gross Return on Sales|Gross Margin ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Return on Gross Profit|ATHE - Gross Profitability|Return on Sales by Gross Profit clene.com CLNN|PEPG: Gross Margin|Gross Return on Sales JUNS|RLMD (Relmada Corp) - Gross Margin|Annovis Bio Inc (ANVS) - Return on Sales by Gross Profit|Gross Profitability Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Gross Profit Rate|Gross Profitability Klotho Neurosciences KLTO|NRSN: Gross Return on Sales|RVPH: Return on Gross Profit|MTVA: Gross Profitability|NRXS (NeurAxis Inc) - Return on Gross Profit|Return on Gross Profit Helius Medical Technologies, Inc.|Gross Profitability Passage Bio Inc.|Gross Profit Margin bionomics.com.au NEUP|Gross Margin NERV|Gross Margin Athira Pharma Inc (ATHA)|Gross Margin ADXN (Addex Therapeutics Ltd.)|ALZN: Gross Return on Sales|CYCN - Gross Profitability|Gross Profit Margin Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Return on Gross Profit|Gross Sales Margin Cortigent, Inc. CRGT|Gross Profitability Avenue Therapeutics, Inc.|Return on Gross Profit BrainStorm Cell Therapeutics Inc. (BCLI)|Gross Profitability Cara Therapeutics, Inc (CARA)|Gross Profitability CHRO (Chromocell Therapeutics Corp.)|Gross Margin ELYM (eliemtx.com)|intracellulartherapies.com - Gross Profitability|LBPH: Return on Gross Profit|Gross Profit Rate MRNS (Marinus Pharma)|NKGN (nkgenbiotech.com) - Return on Gross Profit|Return on Gross Profit NeuroBo Pharmaceuticals|Gross Profitability Synaptogenix, Inc.|Gross Profitability TRVN|Gross Margin VIGL|Gross Margin anewmeds.com (WENA)|Gross Margin CERE (cerevel.com)